Showing 2911-2920 of 20410 results for "".
More Than “Women’s Issues": Women’s Reproductive and Gynaecological Health and Work
https://reachmd.com/programs/global-womens-health-academy/more-than-womens-issues-womens-reproductive-and-gynaecological-health-and-work/9819/This article will review areas of women’s reproductive and gynaecological health, and shine light on what those mean in terms of the workplace.Optimizing Iron Deficiency Management in CKD: IV Iron Replacement Therapy Amid the Latest KDIGO Guidelines
https://reachmd.com/clinical-practice/nephrology/optimizing-iron-deficiency-management-in-ckd-iv-iron-replacement-therapy-amid-the-latest-kdigo-guidelines/54630/Dr. Neuen reviews the most significant updates to the current KDIGO guidelines on the management of anemia in CKD and their relevance to clinical practice.Implementing Guideline-Concordant Care for a Patient With Newly Diagnosed Stage III Melanoma
https://reachmd.com/programs/cme/implementing-guideline-concordant-care-for-a-patient-with-newly-diagnosed-stage-iii-melanoma/36326/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Clinical Evidence: Insights From Early Trials of CDH6-Targeted Therapies
https://reachmd.com/programs/cme/clinical-evidence-insights-from-early-trials-of-cdh6-targeted-therapies/37669/CDH6 in Focus: Advancing Biomarker-Driven Strategies for Platinum-Resistant Ovarian CancerTROPION-Breast02: Evidence for the Approval of Datopotamab Deruxtecan for Patients With mTNBC Ineligible for Immunotherapy
https://reachmd.com/clinical-practice/oncology-hematology/tropion-breast02-evidence-for-the-approval-of-datopotamab-deruxtecan-for-patients-with-mtnbc-ineligible-for-immunotherapy/57281/Join Dr. Tiffany Traina for data from the pivotal TROPION-Breast02 trial and find out what these findings could mean for your clinical practice.Progressive Multiple Sclerosis: Functional, Anatomic, and Biologic Tools to Assess Disability Progression and Improve Patient Outcomes
https://reachmd.com/diseases-diagnoses/ms-immune-disorders/progressive-multiple-sclerosis-functional-anatomic-and-biologic-tools-to-assess-disability-progression-and-improve-patient-outcomes/33143/An enhanced ability to quantify multiple sclerosis disease progression is key for timely optimization of treatment and risk mitigation of worsening disability.Improving Symptoms in Patients with HFrEF Using Novel Device Therapy
https://reachmd.com/programs/cme/improving-symptoms-in-patients-with-hfref-using-novel-device-therapy/14475/Baroreflex activation therapy (BAT) provides durable and sustained benefits for exercise capacity, functional status, and QoL. Tune in to learn more!Women in Aesthetics: Fairyal Day
https://reachmd.com/topics/practice-development/women-in-aesthetics-fairyal-day/48886/Get to know Fairyal Day, Founder of Med Talent, Global Medical Search, an executive search firm specializing in the medical aesthetics, dermatology, dental, and pharmaceutical industriesNeoadjuvant Nivolumab With or Without Ipilimumab in Resectable CSCC
https://reachmd.com/programs/project-oncology/neoadjuvant-nivolumab-with-or-without-ipilimumab-in-resectable-cscc/54700/AAT C-Terminal Peptides Show Independent Prognostic Value in Early-Stage NSCLC
https://reachmd.com/programs/project-oncology/aat-c-terminal-peptides-show-independent-prognostic-value-in-early-stage-nsclc/39032/